Identification of gene clusters differentially expressed during the cellular injury responses (CIR) to cisplatin

British Journal of Cancer

Volumn 85, Issue 8, 2001, Pages 1206-1210

  Johnsson, A ^a   Byrne, P ^a   de Bruin, R ^a   Weiner, D ^a   Wong, J ^a   Los, G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cisplatin; Gene expression; High throughput screening; Suppression subtractive hybridization

Indexed keywords

CISPLATIN; DNA FRAGMENT;

ARTICLE; CELL DAMAGE; CELL HYBRIDIZATION; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DNA LIBRARY; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELL SURVIVAL; CISPLATIN; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MULTIGENE FAMILY; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED;

EID: 0035914251     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2080     Document Type: Article

References (28)

1. Ferritin: A cytoprotective antioxidant strategem of endothelium
2. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin
3. Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug ci-diamminedichloroplatinum(II)
4. Organelle biogenesis: The nucleus, chloroplast and mitochondria
5. Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries
6. Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone
7. Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha
8. Activation of programmed cell death by anticancer agents: Cisplatin as a model system
9. The role of DNA mismatch repair in platinum drug resistance
10. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck
11. The cisplatin-induced cellular injury response
12. Thymosin beta(4) serves as a glutaminyl substrate of transglutaminase. Labeling with fluorescent dansylcadaverine does not abolish interaction with G-actin
13. The stress (heat shock) proteins
14. Identification of genes differentially expressed in association with acquired cisplatin resistance
15. Cisplatin inhibits synthesis of ribosomal RNA in vivo
16. The mechanisms of death of an erythroleukemic cell line by p53: Involvement of the microtubule and mitochondria
17. The yeast growth control gene GRC5 is highly homologous to the mammalian putative tumor suppressor gene QM
18. Identification of human autoantigen La/SS-B as BC1/BC200 RNA-binding protein
19. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line
20. Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance
21. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
22. Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II)
23. Gluconeogenesis
24. Induction and altered localization of 90-kDa heat-shock protein in rat kidneys with cisplatin-induced acute renal failure
25. The mammalian HSF4 gene generates both an activator and a repressor of heat shock genes by alternative splicing
26. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle
27. Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)
28. Gene expression profiles in normal and cancer cells